XGN
Research Snapshot
Static fundamentals, valuation context, and investor signals for Exagen Inc. (XGN).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-49.4%
ROIC, -21.4% FCF margin
Growth
9.7%
5Y sales (revenue) CAGR
Balance sheet
1.3x
Debt/equity, 3.5x current ratio
Superinvestors
1
Top: First Eagle Investment Management (0.0%)
Strengths to research
- Revenue compounded at 9.7% over five years.
- 8 annual periods are available for trend analysis.
Watchouts
- Free cash flow margin is negative at -21.4%.
- Valuation multiples are limited or unavailable.
Annual data: 8 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for XGN.
Grade F
15
/ 100
Financial Charts
No financial data available for XGN (annual).
1 superinvestors own XGN
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 125,242 | $376,000 | 0.00% | 0.0% |